BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Fas ligand (TNF superfamily, member 6)(FASL)

January 21, 2016 8:00 AM UTC

Cell culture and mouse studies suggest inhibiting FASL could help improve the efficacy of adoptive T cell therapy in cancer by disrupting interactions between naïve and mature T cells. In co-cultures ...